Previous Article | Next Article 
Journal of Bacteriology, August 2001, p. 4484-4492, Vol. 183, No. 15
0021-9193/01/$04.00+0 DOI: 10.1128/JB.183.15.4484-4492.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.
Identification, Cloning, Expression, and
Characterization of the Extracellular Acarbose-Modifying
Glycosyltransferase, AcbD, from Actinoplanes sp.
Strain SE50
Michael
Hemker,1
Ansgar
Stratmann,2
Klaus
Goeke,1
Werner
Schröder,3
Jürgen
Lenz,3
Wolfgang
Piepersberg,2,* and
Hermann
Pape1,*
Institut für Mikrobiologie,
Westfälische Wilhelms-Universität, D-48149
Münster,1 Lehrstuhl für
Chemische Mikrobiologie, Bergische Universität GH, D-42097
Wuppertal,2 and Geschäftsbereich
Pharma, TO Biotechnologie, Bayer AG, D-42096
Wuppertal,3 Germany
Received 1 December 2000/Accepted 3 May 2001
 |
ABSTRACT |
An extracellular enzyme activity in the culture supernatant of the
acarbose producer Actinoplanes sp. strain SE50 catalyzes the transfer of the acarviosyl moiety of acarbose to
malto-oligosaccharides. This acarviosyl transferase (ATase) is encoded
by a gene, acbD, in the putative biosynthetic gene cluster
for the
-glucosidase inhibitor acarbose. The acbD gene
was cloned and heterologously produced in Streptomyces
lividans TK23. The recombinant protein was analyzed by enzyme
assays. The AcbD protein (724 amino acids) displays all of the features
of extracellular
-glucosidases and/or transglycosylases of the
-amylase family and exhibits the highest similarities to several
cyclodextrin glucanotransferases (CGTases). However, AcbD had neither
-amylase nor CGTase activity. The AcbD protein was purified to
homogeneity, and it was identified by partial protein sequencing of
tryptic peptides. AcbD had an apparent molecular mass of 76 kDa and an
isoelectric point of 5.0 and required Ca2+ ions for
activity. The enzyme displayed maximal activity at 30°C and between
pH 6.2 and 6.9. The Km values of the ATase for
acarbose (donor substrate) and maltose (acceptor substrate) are 0.65 and 0.96 mM, respectively. A wide range of additional donor and
acceptor substrates were determined for the enzyme. Acceptors revealed a structural requirement for glucose-analogous structures conserving only the overall stereochemistry, except for the anomeric C atom, and
the hydroxyl groups at positions 2, 3, and 4 of D-glucose. We discuss here the function of the enzyme in the extracellular formation of the series of acarbose-homologous compounds produced by
Actinoplanes sp. strain SE50.
 |
INTRODUCTION |
Several aminoglycosidic
-glycosidase inhibitors with C7-cyclitol moieties have been found in
the culture broth of various actinomycetes (20, 30). These
include the
-glucosidase and trehalase inhibitors of the
acarbose-amylostatin group of compounds produced by
Actinoplanes sp. and Streptomyces sp. (9,
21, 38) (Fig. 1), the oligostatins
(26), adiposins (24, 25), and trestatins
(42). Another member group of this class of compounds are
the chitinase inhibitors validamycins and validoxylamines produced by
Streptomyces hygroscopicus var. limoneus
(13). They all contain 1 or 2 U of a valiolol-derived
cyclitol. Since 1990 the
-glucosidase inhibitor acarbose is used in
the therapy of non-insulin-dependent diabetes mellitus. The oral
antidiabetic agent is produced by fermentation of the actinomycete
Actinoplanes sp. strain SE50. Besides acarbose, the organism
produces an extensive series of acarviosyl
{4-N-4,6-didesoxy-4-([4,5,6-trihydroxy-3-hydroxymethyl-2-cyclohexen-1-yl]amino)-
-D-glucopyranose} containing pseudo-oligosaccharides (Fig. 1). These compounds differ in
the number of glucose units connected among each other by
-1,4 glycosidic bonds which are attached to the acarviosyl core at the
reducing and nonreducing ends. The number of glucose units determines
the inhibitory specificity against different
-glycosidases. In
addition, some compounds show variations in the type of the terminal
glycosidic bond or in the nature of the terminal sugar moiety (Table
1).

View larger version (23K):
[in this window]
[in a new window]
|
FIG. 1.
Chemical structures of the acarbose and amylostatin
family of -glucosidase inhibitors from Actinoplanes sp.
strain 50/110. For components marked with an asterisk, the main
ingredient of the isomer mixture with m + n
is 3 (4 or 5).
|
|
The different homologues are formed dependent on the sugar source in
the culture broth (34). If glucose or maltose are supplied as the sole carbon source inhibitors with a small number of glucose units are produced, preferentially acarbose (strong inhibition of
disaccharidases), while addition of starch leads to compounds with a
higher number of glucose units (strong inhibition of amylases). Now it
is known that acarbose in contact with
-amylases and cyclodextrin glucanotransferases (CGTases) in the presence or absence of
maltooligodextrins becomes converted to longer-chain derivatives
containing at least two acarviosyl residues, as shown in crystallized
enzyme-inhibitor complexes (10, 15, 31, 36). Therefore,
acarbose can be regarded as a prodrug which forms more active
inhibitors by the catalytic activity of its target site.
Fermentation experiments with Actinoplanes sp. in the
presence of [U-14C]maltose showed that the maltosyl unit
of acarbose is derived directly from maltose (K. Goeke and H. Pape,
unpublished results). These findings point to an enzymatic activity
responsible for many variations found in acarbose homologues. We
describe here the purification and characterization of the enzyme AcbD
(acarviosyl transferase [ATase]) from the supernatant of
Actinoplanes sp. strain SN223/29 cultures. In addition, the
location of the corresponding gene, encoding the AcbD protein, within
the recently identified biosynthetic gene cluster for acarbose
(35) is shown, and the protein was heterologously produced
in Streptomyces lividans TK23.
 |
MATERIALS AND METHODS |
Bacterial strains, plasmids, medium, and culture conditions.
The Actinoplanes sp. strain SN223/29 used in this study is
an improved acarbose producer developed from the wild-type strain SE
50/110. For purification of the AcbD protein, the organism was
cultivated in a two-stage complex medium. For the preculture stage (72 h), defatted soy flour (Henselwerk, Magstadt, Germany) at 2%, glycerol
at 2%, and CaCO3 at 0.2% in tap water were used; the pH
was adjusted to 7.2 before sterilization. For the inoculation stage, a
4% (vol/vol) inoculum was obtained from a frozen stock. The main
culture (125 ml) was cultivated for 120 h in soluble starch at
3%, defatted soy flour at 1%, and CaCO3 at 0.2% in tap water, with a 4% (vol/vol) preculture inoculum. The cultivation was
carried out in Erlenmeyer flasks at 28°C and 150 rpm in a rotary
shaking incubator. S. lividans 66 strain TK23
(12) was used as the host strain for the heterologous
expression of the AcbD protein. The strain was routinely cultured at
28°C on SMA agar plates (7), and liquid cultures were
carried out in TSB medium (12). The strain
Actinoplanes SE50/110 was cultivated in acarbose-production
medium [MD-50(maltodextrins), 70 g;
(NH4)SO4, 5 g; yeast extract, 2 g;
K2HPO4, 1 g;
KH2PO4, 1 g; Tri-sodiumcitrat, 5 g;
MgCl2 · 6H2O, 1 g;
FeCl3 · 6H2O, 0.25 g; and
CaCl2 · 2H2O, 2 g, all dissolved in
1,000 ml of H2O, with pH adjusted to 6.8, and sterilized by
filtration]. The isolation of the plasmids pAS5 and pAS6, with 10.7-kb
SstI and the 12.4-kb BglII inserts of
Actinoplanes sp. DNA, respectively, was described earlier
(35) (Fig. 2). Cloning
experiments with Escherichia coli were performed using the
plasmids pUC18 (41) and pUWL201 (8) and the
host strain DH5
[F
80d lacZ
M15
endA1 recA1 hsdR17 (rK
mK+)
supE44 thi-1
gyrA96 relA1
(lacZYA-argF)U169 (11)], which was grown at 37°C in Luria-Bertani (LB) broth or on LB agar plates supplemented with ampicillin (100 µg/ml) (33). To
maintain the pUWL201 derivatives in the corresponding S. lividans strains, the media were supplemented with thiostrepton
(25 µg/ml).

View larger version (19K):
[in this window]
[in a new window]
|
FIG. 2.
Map location of the acbD gene within the
putative biosynthetic gene cluster for acarbose. The restriction sites
flanking the inserts of 10.7-kb SstI and 12.4-kb
BglII of Actinoplanes sp. DNA in plasmids pAS5
and pAS6 (35), respectively, are given in bold face. The
transcriptional direction and the relative sizes of the predicted open
reading frames are indicated by bars with arrowheads. The DNA sequence
for this segment is available from the databases under accession no.
AJ293724.
|
|
Purification of ATase.
The culture broth (500 ml) of
Actinoplanes sp. strain SN223/29, grown in main culture
medium, was centrifuged at 2,500 × g for 10 min to
remove the cells. The supernatant was brought to 20% ammonium sulfate
saturation in the cold by adding solid ammonium sulfate. After 2 h
the solution was centrifuged at 25,000 × g for 30 min.
The supernatant was brought to 40% ammonium sulfate saturation and
again centrifuged. The resulting precipitate was dissolved overnight in
100 ml of 25 mM Tris-HCl buffer (pH 8.5), containing 10% glycerin-1
mM CaCl2 and then cleared by centrifugation. The enzyme
solution was applied to a Fractogel DEAE anion exchanger (Merck,
Darmstadt, Germany) column (2 by 16 cm) previously equilibrated with 25 mM Tris-HCl buffer (pH 8.5). Under these conditions the enzyme did not
bind to the anion exchanger. The column was washed with 50 ml of the
same buffer. The combined effluent was dialyzed overnight against the
same buffer. The desalted enzyme solution was again applied to the same
anion exchanger, and the column was washed with the equilibrating
buffer. Proteins were eluted by applying a linear NaCl gradient in the
same buffer (300 ml, 0 to 1 M NaCl, flow rate of 0.5 ml/min). The
active fractions (0.15 to 0.3 M NaCl) collected from the column were
pooled, 100 mg of prepared starch (see below) per ml was added, and the
mixture was stirred overnight and then centrifuged at 40,000 × g for 1 h. The resulting pellet was homogenized in 30 ml
of buffer (25 mM Tris-HCl [pH 7.5] plus 1 mM CaCl2)
containing 25 mM acarbose, stirred at 20°C for 2 h, and then
centrifuged (as described above). The supernatant was dialyzed against
10 mM Tris-HCl (pH 7.5) and 1 mM CaCl2 for 2 days with
several changes of the buffer and then treated again with the prepared
starch. From the resulting pellet, the enzyme was desorbed by
incubation with a 250 mM maltose solution in 10 mM Tris-HCl (pH 7.5)
and 1 mM CaCl2 at 4°C overnight. The resulting
supernatant after centrifugation (as described above) was dialyzed
against 0.1 mM Tris-HCl buffer (pH 7.2) and 0.01 mM CaCl2
for 2 days with several changes of buffer.
For the preparation of starch, soluble starch (100 mg/ml of water) was
incubated for 20 min at 121°C and then precipitated
for 4 days at
4°C. After centrifugation at 40,000 ×
g for 1 h,
the pellet was homogenized in Tris-HCl buffer (25 mM at pH 8.5
containing 10% glycerin and 1 mM CaCl
2) and centrifuged.
The pellet
was used for the starch adsorption of the
ATase.
Determination of ATase activity.
The enzyme assay used for
ATase activity determination is based upon the transfer of the
acarviosyl moiety of acarbose (donor) to radioactive maltose (acceptor)
(reaction A, see below). The standard assay used for determination of
the ATase activity is based on this exchange reaction. With other
sugars the catalyzed reaction has to be formulated as in reaction B.
| |
(A) acarbose + maltose* acarbose* + maltose
|
| |
(B) acarbose + ROH acarviosyl-OR + maltose
|
where an asterisk indicates a radioactively labeled
sugar. After the incubation of unlabeled acarbose with
[
14C]maltose, the amount of radioactivity found in
acarbose depends
on the incubation time and the enzyme activity in the
added protein
solution.
A 10-µl volume of appropriately diluted enzyme solution was mixed
with 4 µl of the reaction solution consisting of 0.25 M
Tris-maleinate buffer (pH 6.3), 19.6 mM acarbose, and 1.75 mM
[U-
14C]maltose (44,000 dpm). This mixture was incubated
at 30°C for
normally 15 min. The reaction was stopped by adding 100 µl of
ethanol. After centrifugation to remove precipitated protein,
the radioactive acarbose was separated from radioactive maltose
by
adding the supernatant to a suspension (500 µl) of Dowex 50
WX 4 (Serva, Heidelberg, Germany), H
+-form, in demineralized
water (1:1; vol/vol). To remove the unbound
radioactive maltose, the
supernatant was taken off, the resin
was washed three times with 500 µl of water, and the washings
were collected. Acarbose was eluted
from the cation exchanger
with 0.5 M ammonia solution (three times with
500 µl). In both
fractions the radioactivity was measured by
scintillation counting.
The relative amount of radioactivity in the
acarbose fraction
(the exchange rate, typically between 5 and 50% of
the total radioactivity
applied per assay, was corrected by the
exchange rate of a control
assay stopped directly with ethanol after
addition of the reaction
solution) is used as measure for enzyme
activity.
Protein concentration was determined according to the method of
Bradford (
5).
Substrate specificity and enzyme kinetics.
The
Km and relative Vmax
values of ATase for acarbose and maltose were calculated from
Lineweaver-Burk plots. The data were obtained through standard
incubation tests (see above), with a constant concentration (10 mM) of
one substrate and varied concentrations (0.1 to 6 mM) of the other
substrate. Assays for the determination of acceptor specifity consisted
of ATase preparation (15 nkat/ml) in buffer (0.1 mM Tris-HCl, 0.01 CaCl2; pH 7.2), acarbose (23 mM), and different acceptor
substrates (23 mM each) in a total volume of 30 µl. The incubation
was stopped after 18 h by adding 70 µl of ethanol. After
centrifugation the supernatant was analyzed by thin-layer
chromatography (TLC) and high-pressure liquid chromatography (HPLC)
(see below). The donor specificity was tested by use of the purified
ATase in similar reaction mixtures with the same buffer system and
volume, but with maltose (200 mM) and different mixtures of acarbose
homologues (16.6 mg/ml) as acceptor and donor substrates, respectively.
The incubation was stopped after 0 and 24 h by adding ethanol, and
the supernatant obtained after centrifugation was analyzed by HPLC (see below).
Further enzyme characterization.
For the determination of
temperature and pH stability of the ATase activity, the assay mixture
was incubated at various temperatures (18 to 67°C) and pH values (70 mM Tris-maleinate buffer [pH 5 to 8.4] at 30°C). The
thermostability of the enzyme was estimated through preincubation of
the ATase preparation at different temperatures (see above) for 15 min,
followed by standard enzyme assay at 30°C. The effect of metal ions
was analyzed for 1 mM additions of CaCl2, MgCl2, MnCl2, FeCl2,
FeCl3, CoCl2, CuSO4,
ZnSO4, and EDTA after incubation at 4°C for 72 h.
Sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE)
was done by the method of Laemmli (16). Marker proteins
with molecular weights ranging from 205,000 to 29,000 (Fluka, Buchs,
Switzerland) were used for estimation of the molecular weight of ATase.
The isoelectric point was determined by isoelectric focusing (IEF)
using ampholyte (Serva) for a pH gradient from 3 to 10 and marker
proteins with isoelectric points from 3.6 to 9.3 (Sigma, Deisenhofen, Germany).
TLC.
The acceptor specifity assays were analyzed by TLC with
silica gel plates (Merck, Darmstadt, Germany), which were developed with butanol-ethanol-H2O (5:3:2 [vol/vol/vol]). The spots
were visualized by spraying the plate with ceric sulfate reagent
[phosphomolybdic acid · H2O (25 g),
cer(IV)-sulfate · 4H2O (10 g), concentrated H2SO4 (60 ml), demineralized water (940 ml)]
followed by heating (15 min at 110°C).
HPLC.
The acceptor specificity assays were analyzed by HPLC
on a Carbopac PA 1 anion-exchange column (4 by 250 mm; Dionex, Idstein, Germany), with a gradient formed by solvent A (0.1 M NaOH) and solvent
B (0.1 M NaOH, 0.5 M sodium acetate) as eluent at a flow rate of 1 ml/min (time:%A values = 0:100, 10:92, 30:90, 45:35, 46:0, 48:0,
49:100, and 58:100). Peaks were recorded with a pulsed electrochemical
detector (Model HP 1049 A; Hewlett-Packard, Ratingen, Germany) with
measuring voltage of 0.1 V 0.2 s and a pulse voltage of 0.6 V
0.08 s and
0.6 V 0.08 s.
The donor specificity assays were analyzed with an NH
2
column (4 by 250 mm; Shandon Hypersil APS 1 [5 µm]; refill by Muder
und Wochele, Berlin, Germany), with an eluent formed by 75%
acetonitrile
and 25% 5 mM potassium hydrogen phosphate buffer (pH 6.8)
at a
flow rate of 2.5 ml/min and at 35°C. Acarbose homologues peaks
were recorded at 210 nm with a UV 1000 detector (Thermo Separation
Products, Darmstadt,
Germany).
General DNA manipulation techniques.
Restriction enzymes and
T4 DNA ligase were purchased from Life Technologies (Eggenstein,
Germany) and used in accordance with the manufacturer's instructions.
DNA fragments were recovered from agarose gels using the JetSorb Kit
(Genomed, Bad Oeynhausen, Germany). DNA manipulations of E. coli were done as described by Sambrook et al. (33);
transformations of E. coli were carried out by the method of
Hanahan (11). Protoplast preparation and plasmid
transformations techniques for S. lividans were performed according to published procedures (2, 12).
Identification, cloning, and expression of the acbD
gene.
The acbD gene was identified as a part of the
biosynthetic gene cluster for acarbose in Actinoplanes
strain SE50/110 by using the recombinant plasmid pAS5. A 2.6-kb
HindIII/PstI DNA fragment was isolated from
pAS5 and ligated into pUC18 in E. coli DH5
. The resulting
recombinant plasmid pAS5/15.1 was analyzed by DNA sequencing. One open
reading frame of 2,172 bp was identified and named acbD. For
the expression of acbD in S. lividans TK23 under
the control of the ermEp promoter, the 2.6-kb
HindIII/PstI DNA fragment was cloned into
pUWL201 HindIII/PstI, resulting in pAS9. To
remove the 126-bp sequence upstream of the GTG start codon of the
acbD gene (Fig. 3), pAS9 was
hydrolyzed with the enzyme EcoNI. After treatment with the
Klenow enzyme (Roche, Mannheim, Germany) and hydrolysis with
BamHI, a 2.5-kb DNA fragment was isolated and cloned in
pUC18 HincII/BamHI resulting in pAS5/15.1.1. The
deletion of the 126 bp was controlled by DNA sequencing. The shortened
acbD DNA fragment was reisolated as a
HindIII/BamH1 fragment and ligated into
pUWL201 HindIII/BamHI, resulting in pAS9-2.
The strains S. lividans TK23/pAS9 and S. lividans
TK23/pAS9-2 were cultivated in 10 ml of TSB medium for 3 to 4 days, and
the supernatants were dialyzed for 12 h at 4°C against buffer (5 mM Tris-HCl, 1 mM CaCl2; pH 7.5). To test the extracellular
production of the AcbD protein, 500 µl of the desalted supernatants
was concentrated under vacuum and analyzed by SDS-PAGE (8%
polyacrylamide [PAA] gel).

View larger version (22K):
[in this window]
[in a new window]
|
FIG. 3.
Putative regulatory region upstream of the
acbD reading frame. Inverted- and direct-repeat structures
are marked by arrows. The possible ribosome-binding site and a possible
promoter region ( 10, 35) with similarity to E. coli
70-like Streptomyces sp. promoters are marked
by underlining. The recognition sites for restriction enzymes are
indicated.
|
|
DNA sequencing, computer analysis of DNA sequences, and accession
number of the nucleotide sequence.
Various overlapping restriction
fragments of the 2.6-kb HindIII/PstI DNA
fragment insert in pAS5/15.1 were subcloned in pUC18 and sequenced by
the dideoxynucleotide chain termination method (32) using
an AutoRead sequencing kit and an A.L.F. DNA sequencer (Amersham
Pharmacia Biotech, Freiburg, Germany). The entire sequences of both
strands were determined from double-stranded plasmid DNAs prepared by
the alkaline lysis method (33). The DNA sequences were
analyzed using DNA-Strider 1.2 (19) and BrujeneII sequence analysis software. Homology searches were performed against EBI, GenBank, and SWISSPROT data libraries using BLAST (1) and
FASTA 1.4×2 (27) software. The accession number of the
nucleotide sequence is AJ293724.
Protein sequencing.
About 500 µg of the purified AcbD
protein was dissolved in 1 ml of 6 M guanidinium hydrochloride-0.5 M
Tris-(hydroxymethyl)-aminomethane (pH 8.6). Then, 5 µl of 1 M
dithiothreitol was added, and the sample was reduced at 54°C for
about 18 h. Next, 10 µl of 2 M sodium iodoacetate solution was
added, and the sample was incubated in the dark for 35 min. After
dialysis against 0.5 M urea-0.1 M ammonium hydrogen carbonate solution
(buffer change after 2 and 4 h; total time of dialysis about
6 h; dialysis tube cutoff, 3.5 kDa). The sample was digested by
adding 5 µg of bovine trypsin (sequence grade) at 37°C for 18 h. The sample was concentrated before HPLC analysis to about 500 µl
by centrifugal evaporation in a Speedvac. The tryptic peptides were
separated by HPLC using an HP1090 system equipped with a diode array
detector 1040A, a chemstation, and a fraction collector. The HPLC
components were from Hewlett-Packard (Waldbronn, Germany), and the
fraction collector, Superrac 2211, was from Pharmacia (Freiburg,
Germany). A Nucleosil RP-18 column (250 by 4.6 mm; 5-µm spheres;
300-Å pore diameter) from CS-Chromatographie Service
(Langerwehe, Germany) was used for peptide separation. The collected
peptides were used for sequence analysis. N-terminal sequence analyses
of ATase samples were performed using the gas-liquid-solid-phase
protein sequencer 473A from Applied Biosystems (Foster City, Calif.).
The standard sequencer program FAST Normal was used. The sequencer, the
different running programs, and the cycles, as well as the
phenylthiohydantoin (PTH) separation system, are described in detail in
the respective user manuals (i.e., for protein sequencing system model
473A [1989]; Applied Biosystems). The detection of PTH amino acids
were performed online using an RP18-PTH column (220 by 2 mm, 5-µm
spheres) from Applied Biosystems.
 |
RESULTS |
Production, purification, and properties of the ATase of
Actinoplanes sp. strain SN223/29.
The extracellular
ATase is optimally produced in starch-containing media. The enzyme was
purified from the supernatant of soyflour starch cultures by a
five-step procedure (as described in Materials and Methods):
precipitation with ammonium sulfate, two ion-exchange chromatography
steps, and two adsorption-elution steps using starch as the adsorbent
and acarbose or maltose as the desorbing agents. Although the latter
two steps are effective in obtaining a purification of ATase, the
nature of the interaction between starch and enzyme is currently not
clear. Perhaps, starch, maltose, and acarbose interact with the active
center or a starch-binding site of the enzyme, similar to the
raw-starch-binding sites described for CGTases (17).
The ATase was purified 18-fold to give a homogeneous preparation (as
shown by SDS-PAGE and IEF) with a specific activity of
77 nkat/mg
(Table
2). The molecular mass of the
enzyme was 76
kDa, and it had an isoelectric point of 5.0. The addition
of Ca
2+ ions led to an enhanced enzyme activity
corresponding to the
total inhibition by addition of EDTA. The enzyme
is thermostable
up to 40°C and displays a slight maximum of activity
at 30°C.
The optimal pH for enzyme activity was determined to be
between
pH 6.2 and 6.9. The
Km values of ATase
for acarbose and maltose
are 0.65 and 0.96 mM, respectively.
The partial amino acid sequence of seven peptides out of the purified
ATase were determined by digestion with trypsin and
subsequent
sequencing by Edman degradation (Fig.
4).
These tryptic
peptides were identified in the deduced amino acid
sequence of
the
acbD gene encoding the ATase (see below).

View larger version (77K):
[in this window]
[in a new window]
|
FIG. 4.
Alignment of the protein sequences of the ATase AcbD
with those of several CGTases. The proteins aligned were from the
following organisms (with GenBank and EBI database accession codes in
parentheses): Ac., Actinoplanes sp. (AJ293724); T. ther.,
Thermoanaerobacterium thermosulfurigenes (P26827); B. cir.,
Bacillus circulans 251 (P43379); P. mar.,
Paenibacillus macerans (P31835); and K. pneu.,
Klebsiella pneumoniae (P08704). The three acidic amino acid
residues of the active site (catalytic triade), which are also
conserved in most of the proteins of the amylase family, are shown in
boldface (15). The amino acid residues identified to
participate in the binding of acarbose to the CGTase are boxed
(36); the aromatic amino acid residue identified to be
crucial for the CGTases (28), which is changed to A in
AcbD, is marked by a delta symbol ( ). Residues identical
in all four sequences are marked by an asterisk; those where side
chains are replaced by similar ones are labeled by a dot. The partial
protein sequences as determined from tryptic peptides of the purified
ATase from Actinoplanes sp. strain 223/29 are underlined.
|
|
Donor and acceptor substrates of the ATase.
The ATase accepted
a wide range of substrates, including glucose, maltooligosaccharides,
dextrin, and amylopectin (Table 3). In
standard ATase assays, using unlabeled maltose or the other compounds
as competing substrates for radioactively labeled maltose, none of
these compounds was as efficient an acarviosyl acceptor as was maltose
itself. Interestingly, the glucosides of aliphatic alcohols were also
good acceptor substrates for the ATase, with the highest rate measured
for nonyl-
-glucopyranoside. As donor substrates, component 2 (acarviosyl glucose) and component 4b (acarviosyl maltotriose) were
identified. The incubation of these substrates with maltose in the
presence of purified ATase resulted in the formation of acarbose (Table
4). Only components A and C (Table 1) did
not act as acarviosyl donors in an ATase-catalyzed reaction. In
addition, component C (acarviosyl trehalose) was not formed by the
ATase in the presence of acarbose and trehalose. So this component,
which reaches high concentrations in fermentations of
Actinoplanes sp., probably does not originate from the
activity of the ATase. Component A arises by chemical modification
reactions during the purification procedure of acarbose from the
culture broth (Bayer AG, unpublished results), and so it is not a
pseudo-oligosaccharide biosynthesized by the bacterium.
Identification and characterization of the gene for ATase in
Actinoplanes sp.
The acbD gene encoding the
ATase was identified in the DNA region adjacent to the
already-characterized 3.4-kb genomic region (accession no. Y18523) of
the biosynthetic gene cluster for the aminoglycoside acarbose in
Actinoplanes sp. strain 50/110 (Fig. 2). An internal 2.6-kb
HindIII/PstI DNA fragment of the plasmid pAS5
contained a single reading frame of 2,172 bp showing the typical codon
bias found for genes from actinomycetes (4). In the
deduced amino acid sequence, the seven tryptic peptides out of the
purified ATase were identified (Fig. 4). This clearly indicates the
described reading frame as the acbD gene.
Heterologous expression of the ATase in S. lividans.
The acbD gene was expressed in S. lividans under the control of the constitutive
ermEup promoter by using the vector pAS9. In the
dialyzed supernatants of a cultivation of S. lividans/pAS9 a
strong additional protein band was visible in comparison to the vector
control experiment (Fig. 5, lanes 1 and
2, respectively). As a standard, the dialyzed supernatant of
Actinoplanes strain SE50/110 after cultivation in acarbose
production medium is shown (Fig. 5, lane 3). To prove the heterologous
expression of acbD, the ATase activity in the corresponding
supernatants was measured. The specific activity of the recombinant
ATase was 2.9 nkat/mg, and for the parental enzyme it was 0.65 nkat/mg
(Fig. 5, lanes 2 and 3, respectively). In the supernatants of the
vector control (Fig. 5, lane 1), no ATase activity was detectable.

View larger version (107K):
[in this window]
[in a new window]
|
FIG. 5.
Extracellular expression of AcbD in S. lividans TK23. The lanes of the gel (0.1% SDS-8%
polyacrylamide) contained samples of lyophilized protein from 500 µl
of dialyzed culture supernatant from each of the following strains (for
details of conditions, see Materials and Methods): lane 1, S. lividans TK23/pUWL201 (cultured in TSB medium); lane 2, S. lividans TK23/pAS9 (cultured in TSB medium); lane 3, Actinoplanes sp. strain SE50/110 (cultured in acarbose
production medium); left lane, molecular weight marker. The location of
the AcbD band is indicated.
|
|
The expression of
acbD using the
ermEup promoter shows an unstable phenotype in
S. lividans. In order to reproduce the heterologous
expression of
acbD, the plasmid pAS9 has to be transformed
anew
into protoplasts of
S. lividans and even so only a few
of the
resulting
S. lividans/pAS9 strains again produced the
AcbD protein.
To overcome this problem, the putative regulatory region
upstream
acbD was eliminated by leaving the putative
ribosome-binding site
(Fig.
3). The resulting
S. lividans/pAS9-2 strain did not produce
the AcbD protein. Both
plasmids pAS9 and pAS9-2 were still present
in the corresponding
strains, and no changes or DNA rearrangements
were detectable by
analysis using different restriction enzymes
(data not
shown).
Structural properties of the ATase and comparison to CGTases.
The AcbD protein shows significant similarity to members of the
-amylase superfamily of proteins. Among these groups the similarity
is highest to the CGTases. AcbD retains the domain structure of
CGTases, including the domains D and E for raw-starch binding
(14, 29, 40). There are no actinomycete CGTases known so
far. Therefore, the closest relatives are from other bacterial orders.
The highest similarity scores (39 to 42%) were found with CGTases from
the low-G+C gram-positive bacteria Bacillus circulans,
Paenibacillus macerans, and Thermoanaerobacterium
thermosulfurigenes and from the gram-negative bacterium
Klebsiella pneumoniae (Fig. 4). The three acidic amino acid
residues of the active site, e.g., the catalytic triade of D229, E257,
and D331 in the CGTase of B. circulans 251 (15), which are also conserved in most of the proteins of
the amylase family, are also present in the AcbD protein (Fig. 4). Most
of the amino acid residues identified to participate in the binding of
substrates and of the inhibitor acarbose in amylase and CGTase proteins
of various organisms are also conserved (10, 18, 36, 37).
However, the crucial aromatic amino acid residue in CGTases (Y or F at
position 195; numbering system taken from the B. circulans
251 CGTase; Fig. 4) for the cyclization reaction of
malto-oligosaccharides to
-,
-, and
-cyclodextrins (23,
28) has been replaced by an A in AcbD. In this feature the ATase
is more similar to
-amylases, in which this position is also
occupied by smaller amino acid residues (G, S, T, V, or L)
(40).
 |
DISCUSSION |
Structure-function relationships of the ATase in comparison to
CGTases.
The ATase, as a member of the
-amylase superfamily,
adds an interesting new type of catalytic specificity and substrate
selectivity to this group of proteins: all members of the
-amylase
family tested thus far bind acarbose and are inhibited by it but do not convert acarbose quantitatively. However, the ATase AcbD has neither
-amylase nor CGTase activity. The AcbD protein clearly belongs to
the CGTase subfamily, exhibits solely transglycosylation activity on
donor substrates containing the acarviosyl moiety, and accepts a wide
range of acceptor substrates as shown in Fig.
6. Thus, the stronger transglycosylating
activity of the CGTases, catalyzing a mixture of hydrolytic and group
transfer reactions on various substrate lengths of
-1,4-glucosidic
chains (22, 40), has been shifted during the evolution of
AcbD toward a restriction of transferase activity and to substrates
with smaller chain lengths. However, the strong binding of AcbD protein
to starch and the structure of the protein chain suggest that the
raw-starch-binding domain E is retained fully active but probably does
not participate in catalysis or substrate binding as in the CGTases
(29). Of the three types of transglycosylating activities
which can be distinguished on the CGTases (22), only the
so-called disproportionation reaction on
-1,4-glucosidic donors and
acceptors resembles part of the ATase-catalyzed reactions and,
therefore, could also follow a ping-pong mechanism (3,
39). The overall activities of both
-amylases and CGTases in
the presence of acarbose seem, however, to be similar, since both
enzyme groups use acarbose as donors and catalyze transglycosylation of
parts of acarbose to either itself or other acceptors (10, 31,
36, 37) (Fig. 7). By this means,
elongated and firmly bound inhibitors with a much higher inhibitor
activity are formed, but with significant differences in their binding
specificity in the catalytic site: (i) in the porcine pancreatic
amylase II, these are positioned with the bridging pseudoglycosidic
imino group of an acarviosyl moiety; and (ii) in the CGTase of B. circulans 251, the formed maltononaose inhibitor is positioned
with the glycosidic bond between the reducing end of the acarviosyl
moiety and the maltose. Based on these observations and the results
presented here, a model for the binding specificity of the acarviosyl
residue in the catalytic site of the ATase at positions +1 and +2 can
be derived (Fig. 7).

View larger version (8K):
[in this window]
[in a new window]
|
FIG. 6.
Acceptor specificity of the ATase (for details, see the
text). R1 = H; OH; CH2PH; CH3.
R2 = H;
(CH2)mCH3,
m = 0 to 9; pyranoses [ (1 2); (1 3);
(1 4); (1 6); (1 2); (1 3); (1 4)]; furanoses
[ (1 6)]; glucit; phenyl-; nitrophenyl-; etc. R3 = O; S; CHOH.
|
|

View larger version (19K):
[in this window]
[in a new window]
|
FIG. 7.
Comparison of catalytic mechanisms of -amylase,
CGTase, and ATase in the presence of acarbose alone or together with
D-glucose (Glc) or maltooligodextrins
(Maln) as transglycosylation donors or
acceptors. The location of the substrate or inhibitor product,
respectively, relative to the catalytic site (cat.) is indicated. The
plain or crossed arrows indicate the ability or inability,
respectively, to split the glycosidic bonds. The enzymes and data are
as follows: PPA11, porcine pancreatic amylase II (10, 18);
CGTase, CGTase from B. circulans 251 (28);
ATase, AcbD, ATase (This study).
|
|
Donor and acceptor specificity of the ATase.
The reaction
measured by the standard enzyme assay between acarbose and maltose
probably does not represent a physiologically significant role of the
ATase. Glucose, maltooligosaccharides, dextrin, and amylopectin were
accepted with distinct transfer rates. In addition, the glucosides of
aliphatic alcohols were also good acceptor substrates for the ATase,
with the highest rate measured for nonyl-
-glucopyranoside. It is
tempting to speculate that the enzyme may be responsible for the final
step in the acarviosyl export: the transfer of an acarviosyl moiety
from a membrane carrier (perhaps anchored in the membrane by an
aliphatic moiety) to extracellular saccharides. However, the fact that
other sugars are accepted as substrates indicates a central role of the
ATase for the formation of the observed diversity of acarbose-related
pseudo-oligosaccharides by Actinoplanes sp.
Taken together, the data in Table
3 allow us to draw a generalized
structure for acceptor substrates of ATase (Fig.
6). This
general model
ignores the different acceptor efficiencies of the
substrates. The
basic structure is a pyranose ring with equatorial
hydroxyl groups at
C2, C3, and C4. At three positions substitution
of the pyranose ring
appears to be tolerated, as indicated in
Fig.
6. The heteroatom in the
pyran ring could be replaced by
C or S. A preference for

- over

-glycosidic binding of the sugar,
polyol, or aromatic residues at
the anomeric hydroxyl was observed.
The structures of donor substrates
used by ATase (Table
4) correspond
to this general model. Incubation of
component 2 (acarviosyl glucose)
and component 4b (acarviosyl
maltotriose) with maltose resulted
in the formation of acarbose (Table
4). Therefore, we generalize
that the 4-hydroxyl group at the
nonreducing end of the maltosaccharides
can accept the acarviosyl
moiety by the action of
ATase.
Possible physiological role for ATase and acarbose in the ecology
of Actinoplanes sp. strain SE50.
The ATase is probably
responsible for the formation of the various pseudooligosaccharides
observed in cultures of Actinoplanes sp., containing
oligosaccharide chains of different lengths and compositions at the
"reducing end" of the acarviosyl moiety, with the exception of
components A and C. The dominant acceptor substrates in the
extracellular matrix are the malto-oligosaccharides, originating from
starch utilization by Actinoplanes. Taking into
consideration the inhibitory action of acarbose and related
pseudo-oligosaccharides toward
-glucosidases, one could envisage a
central role of ATase in sugar utilization by the acarbose producer.
The extracellular starch degradation by amylases from
Actinoplanes sp. (or competing organisms in more natural
environments) leads to the production of dextrins and
malto-oligosaccharides. ATase transfers acarviosyl moieties to these
saccharides, generating effective inhibitors for starch-degrading
"foreign" enzymes, such as the acarbose-sensitive bacterial and
fungal
-amylases of microbial competitors (20, 38).
This system would be even more efficient for the producer if the
acarbose family of inhibitors would also prevent the uptake of
malto-oligodextrins by other microbes. In this context, the efficient
inhibition of the maltose-binding protein MalE from E. coli
by acarbose is interesting to note (6). Since the acarbose producer still grows on starch in the presence of even high acarbose concentrations, it must contain an acarbose-insensitive
starch-degrading enzyme system. Together, this could result in a
successful competition for a needed carbon source. This seems to be the
case, since at least one extracellular
-amylase, AcbE, of
Actinoplanes sp. is acarbose resistant (A. Stratmann and W. Piepersberg, unpublished results).
 |
ACKNOWLEDGMENT |
We thank Udo F. Wehmeier for comments on the manuscript.
 |
FOOTNOTES |
*
Corresponding authors. Mailing address for Hermann
Pape: Institut für Mikrobiologie, Westfälische
Wilhelms-Universität, Corrensstr. 3, D-48149 Münster,
Germany. Phone: (49) 251-833-9824. Fax: (49) 251-833-8388. E-mail:
pape{at}uni-muenster.de. Mailing address for Wolfgang
Piepersberg: Chemische Mikrobiologie, Bergische Universität GH,
Gauss-Str. 20, D-42097 Wuppertal, Germany. Phone: (49)
202-439-2521. Fax: (49) 202-439-2698. E-mail:
piepersb{at}uni-wuppertal.de.
 |
REFERENCES |
| 1.
|
Altschul, S. F.,
W. Gish,
W. Miller,
E. W. Myers, and D. J. Lipmann.
1990.
Basic local alignment search tool.
J. Mol. Biol.
215:403-410[CrossRef][Medline].
|
| 2.
|
Babcock, M. J., and K. E. Kendrick.
1988.
Cloning of DNA involved in sporulation of Streptomyces griseus.
J. Bacteriol.
170:2802-2808[Abstract/Free Full Text].
|
| 3.
|
Bender, H.
1990.
Studies of the mechanism of the cyclisation reaction catalysed by the wildtype and a truncated -cyclodextrin glycosyltransferase from Klebsiella pneumoniae strain M5, and the -cyclodextrin glycosyltransferase from Bacillus circulans strain 8.
Carbohydr. Res.
206:257-267[CrossRef][Medline].
|
| 4.
|
Bibb, M. J.,
P. R. Findlay, and M. W. Johnson.
1984.
The relationship between base composition and codon usage in bacterial genes and its use for the simple and reliable identification of protein-coding sequences.
Gene
30:157-166[CrossRef][Medline].
|
| 5.
|
Bradford, M. M.
1976.
A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding.
Anal. Biochem.
72:248-254[CrossRef][Medline].
|
| 6.
|
Brunkhorst, C.,
C. Andersen, and E. Schneider.
1999.
Acarbose, a pseudooligosaccharide, is transported but not metabolized by the maltose/maltodextrin system of Escherichia coli.
J. Bacteriol.
181:2612-2619[Abstract/Free Full Text].
|
| 7.
|
Distler, J.,
K. Mansouri, and W. Piepersberg.
1985.
Streptomycin biosynthesis in Streptomyces griseus. II. adjacent genomic location of biosynthetic genes and one of two streptomycin resistance genes.
FEMS Microbiol. Lett.
30:151-154[CrossRef].
|
| 8.
|
Doumith, M.,
P. Weingarten,
U. F. Wehmeier,
K. Salah-Bey,
B. Benhamou,
C. Capdevilla,
J.-M. Michel,
W. Piepersberg, and M.-C. Raynal.
2000.
Analysis of genes involved in 6-deoxyhexose biosynthesis and transfer in Saccharopolyspora erythraea.
Mol. Gen. Genet.
264:477-485[CrossRef][Medline].
|
| 9.
|
Fukuhara, K.,
H. Murai, and S. Murao.
1982.
Isolation and structure-activity relationship of some amylostatins (F-1b fraction) produced by Streptomyces diastaticus subsp. amylostaticus.
Agric. Biol. Chem.
46:1941-1945.
|
| 10.
|
Gilles, C.,
J. P. Astier,
G. Marchis-Mouren,
C. Cambillau, and F. Payan.
1996.
Crystal structure of pig pancreatic alpha-amylase isoenzyme II, in complex with the carbohydrate inhibitor acarbose.
Eur. J. Biochem.
238:561-569[Medline].
|
| 11.
|
Hanahan, D.
1983.
Studies on transformation of Escherichia coli with plasmids.
J. Mol. Biol.
166:557-580[Medline].
|
| 12.
|
Hopwood, D. A.,
M. J. Bibb,
K. F. Chater,
T. Kieser,
C. J. Bruton,
H. M. Kieser,
D. J. Lydiate,
C. P. Smith,
J. M. Ward, and H. Schrempf.
1985.
Genetic manipulation of Streptomyces: a laboratory manual.
The John Innes Foundation, Norwich, United Kingdom.
|
| 13.
|
Horii, S., and Y. Kameda.
1972.
Structure of the antibiotic validamycin A.
J. Chem. Commun.
1972:747-748.
|
| 14.
|
Jespersen, H. M.,
E. A. MacGregor,
M. R. Sierks, and B. Svensson.
1991.
Comparison of the domain-level organization of starch hydrolases and related enzymes.
Biochem. J.
280:51-55.
|
| 15.
|
Knegtel, R. M. A.,
B. Strokopytov,
D. Penninga,
O. G. Faber,
H. J. Rozoboom,
K. H. Kalk,
L. Dijkhuizen, and B. W. Dijkstra.
1995.
Crystallographic studies on the interaction of cyclodextrin glycosyltransferase from Bacillus circulans strain 251 with natural substrates and products.
J. Biol. Chem.
270:29256-29264[Abstract/Free Full Text].
|
| 16.
|
Laemmli, U. K.
1970.
Cleavage of structural proteins during the assembly of the head of bacteriophage T4.
Nature
227:680-685[CrossRef][Medline].
|
| 17.
|
Lawson, C. L.,
R. Van Montfort,
B. Strokopytov,
H. J. Rozeboom,
K. H. Kalk,
G. E. De Vries,
D. Penninga,
L. Dijkhuizen, and B. W. Dijkstra.
1994.
Nucleotide sequence and X-ray structure of cyclodextrin glycosyltransferase from Bacillus circulans strain 251 in a maltose-dependent crystal form.
J. Mol. Biol.
236:590-600[CrossRef][Medline].
|
| 18.
|
Machius, M.,
L. Vertesy,
R. Huber, and G. Wiegand.
1996.
Carbohydrate and protein-based inhibitors of porcine pancreatic alpha-amylase: structure analysis and comparison of their binding characteristics.
J. Mol. Biol.
260:409-421[CrossRef][Medline].
|
| 19.
|
Mark, C.
1988.
"DNA-Strider": a C program for the fast analysis of DNA and protein sequences on the Macintosh family of computers.
Nucleic Acids Res.
16:1829-1836[Abstract/Free Full Text].
|
| 20.
|
Müller, L.
1989.
Chemistry, biochemistry and therapeutic potential of microbial -glucosidase inhibitors, p. 109-116.
In
A. L. Demain, G. A. Somkuti, J. C. Hunter-Creva, and H. W. Rossmoore (ed.), Novel microbial products for medicine and agriculture. Elsevier Science Publishers, Amsterdam, The Netherlands.
|
| 21.
|
Murao, S., and K. Ohyama.
1975.
New amylase inhibitor (S-I) from Streptomyces diastaticus var. amylostaticus no. 2476.
Agr. Biol. Chem.
39:2271-2273.
|
| 22.
|
Nakamura, A.,
K. Haga, and K. Yamane.
1993.
Three histidine residues in the active centre of cyclodextrin glucanotransferase from alkalophilic Bacillus sp. 1011: effects of the replacement on pH dependence and transition-state stabilization.
Biochemistry
32:6624-6631[CrossRef][Medline].
|
| 23.
|
Nakamura, A.,
K. Haga, and K. Yamane.
1994.
Four aromatic residues in the active center of cyclodextrin glucanotransferase from alkalophilic Bacillus sp. 1011: effects of replacements on substrate binding and cyclization characteristics.
Biochemistry
33:9929-9936[CrossRef][Medline].
|
| 24.
|
Namiki, S.,
K. Kangouri,
T. Nagate,
H. Hara,
K. Sugita, and S. Omura.
1982.
Studies on the alpha-glucoside hydrolase inhibitor, adiposin. II. Taxonomic studies on the producing micoorganism.
J. Antibiot.
35:1156-1159[Medline].
|
| 25.
|
Namiki, S.,
K. Kangouri,
T. Nagate,
H. Hara,
K. Sugita, and S. Omura.
1982.
Studies on the alpha-glucoside hydrolase inhibitor, adiposin. I. Isolation and physicochemical properties.
J. Antibiot.
35:1234-1236[Medline].
|
| 26.
|
Omoto, S.,
J. Itoh,
H. Ogino, and K. Iwamatsu.
1981.
Oligostatins, new antibiotics with amylase inhibitory activity. II. Structures of oligostatins C, D and E.
J. Antibiot.
34:1429-1433[Medline].
|
| 27.
|
Pearson, W. R., and D. J. Lipman.
1988.
Improved tools for biological sequence analysis.
Proc. Natl. Acad. Sci. USA
85:2444-2448[Abstract/Free Full Text].
|
| 28.
|
Penninga, D.,
B. Strokopytov,
H. J. Rozeboom,
L. Lawson,
B. W. Dijkstra,
J. Bergsma, and L. Dijkhuizen.
1995.
Site-directed mutations in tyrosine 195 of cyclodextrin glycosyltransferase from Bacillus circulans strain 251 affect activity and product specificity.
Biochemistry
34:3368-3376[CrossRef][Medline].
|
| 29.
|
Penninga, D.,
B. A. van der Veen,
R. M. Knegtel,
S. A. van Hijum,
H. J. Rozoboom,
K. H. Kalk,
B. W. Dijkstra, and L. Dijkhuizen.
1995.
The raw starch binding domain of cyclodextrin glycosyltransferase from Bacillus circulans strain 251.
J. Biol. Chem.
271:32777-32784[Abstract/Free Full Text].
|
| 30.
|
Piepersberg, W., and J. Distler.
1997.
Aminoglycosides and sugar components in other secondary metabolites, p. 397-488.
In
H.-J. Rehm, and G. Reed (ed.), Biotechnology, 2nd ed., vol. 7. Products of secondary metabolism. VCH, WeinheimWeinheim, Germany.
|
| 31.
|
Qian, M.,
R. Haser,
G. Buisson,
E. Duée, and F. Payan.
1994.
The active center of a mammalian -amylase. Structure of the complex of a pancreatic -amylase with a carbohydrate inhibitor refined to 2.2-Å resolution.
Biochemistry
33:6284-6294[CrossRef][Medline].
|
| 32.
|
Sanger, F.,
S. Nicklen, and A. R. Coulson.
1977.
DNA sequencing with chain-terminating inhibitors.
Proc. Natl. Acad. Sci. USA
74:5463-5467[Abstract/Free Full Text].
|
| 33.
|
Sambrook, J.,
E. F. Fritsch, and T. Maniatis.
1989.
Molecular cloning: a laboratory manual, 2nd ed.
Cold Spring Harbor Laboratory Press, Cold Spring Harbor, N.Y.
|
| 34.
|
Schmidt, D. D.,
W. Frommer,
B. Junge,
L. Müller,
W. Wingender, and E. Truscheit.
1977.
-Glucosidase inhibitors: new complex oligosaccharides of microbial origin.
Naturwissenschaften
64:535-536[CrossRef][Medline].
|
| 35.
|
Stratmann, A.,
T. Mahmud,
S. Lee,
J. Distler,
H. G. Floss, and W. Piepersberg.
1999.
The AcbC protein from Actinoplanes species is a C7-cyclitol synthase related to 3-dehydroquinate synthases and is involved in the biosynthesis of the -glucosidase inhibitor acarbose.
J. Biol. Chem.
274:10889-10896[Abstract/Free Full Text].
|
| 36.
|
Strokopytov, B.,
D. Penninga,
H. J. Rozoboom,
K. H. Kalk,
L. Dijkhuizen, and B. W. Dijkstra.
1995.
Structure of cyclodextrin glycosyltransferase complexed with acarbose. Implications for the catalytic mechanism of glycosidases.
Biochemistry
34:2234-2240[CrossRef][Medline].
|
| 37.
|
Strokopytov, B.,
R. M. Knegtel,
D. Penninga,
H. J. Rozoboom,
K. H. Kalk,
L. Dijkhuizen, and B. W. Dijkstra.
1996.
X-ray structure of cyclodextrin glycosyltransferase complexed with a maltononaose inhibitor at 2.6 angstrom resolution.
Biochemistry
35:4241-4249[CrossRef][Medline].
|
| 38.
|
Truscheit, E.,
W. Frommer,
B. Junge,
L. Müller,
D. D. Schmidt, and W. Wingender.
1981.
Chemistry and biochemistry of -glucosidase inhibitors.
Angew. Chem. Int. Ed.
20:744-761[CrossRef].
|
| 39.
|
van der Veen, B. A.,
G. J. van Alebeek,
J. C. Uitdehaag,
B. W. Dijkstra, and L. Dijkhuizen.
2000.
The three transglycosylation reactions catalyzed by cyclodextrin glycosyltransferase from Bacillus circulans (strain 251) proceed via different kinetic mechanisms.
Eur. J. Biochem.
267:658-665[Medline].
|
| 40.
|
Wind, R. D.,
R. M. Buitelaar, and L. Dijkhuizen.
1998.
Engineering of factors determining alpha-amylase and cyclodextrin glycosyltransferase specificity in the cyclodextrin glycosyltransferase from Thermoanaerobacterium thermosulfurigenes EM1.
Eur. J. Biochem.
253:598-605[Medline].
|
| 41.
|
Yanisch-Perron, C.,
J. Vieira, and J. Messing.
1985.
Improved M13 phage cloning vectors and host strains: nucleotide sequence of the M13mp18 and pUC19 vectors.
Gene
33:103-119[CrossRef][Medline].
|
| 42.
|
Yokose, K.,
K. Ogawa,
T. Sano,
K. Watanabe,
H. B. Maruyama, and Y. Suhara.
1983.
New -amylase inhibitor, trestatins. II. Structure determination of trestatins A, B and C.
J. Antibiot.
36:1166-1175[Medline]
|
Journal of Bacteriology, August 2001, p. 4484-4492, Vol. 183, No. 15
0021-9193/01/$04.00+0 DOI: 10.1128/JB.183.15.4484-4492.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.
This article has been cited by other articles:
-
Blouzard, J.-C., Bourgeois, C., de Philip, P., Valette, O., Belaich, A., Tardif, C., Belaich, J.-P., Pages, S.
(2007). Enzyme Diversity of the Cellulolytic System Produced by Clostridium cellulolyticum Explored by Two-Dimensional Analysis: Identification of Seven Genes Encoding New Dockerin-Containing Proteins. J. Bacteriol.
189: 2300-2309
[Abstract]
[Full Text]
-
Stam, M. R., Danchin, E. G.J., Rancurel, C., Coutinho, P. M., Henrissat, B.
(2006). Dividing the large glycoside hydrolase family 13 into subfamilies: towards improved functional annotations of {alpha}-amylase-related proteins. Protein Eng Des Sel
19: 555-562
[Abstract]
[Full Text]
-
Zhang, C.-S., Stratmann, A., Block, O., Bruckner, R., Podeschwa, M., Altenbach, H.-J., Wehmeier, U. F., Piepersberg, W.
(2002). Biosynthesis of the C7-cyclitol Moiety of Acarbose in Actinoplanes Species SE50/110. 7-O-PHOSPHORYLATION OF THE INITIAL CYCLITOL PRECURSOR LEADS TO PROPOSAL OF A NEW BIOSYNTHETIC PATHWAY. J. Biol. Chem.
277: 22853-22862
[Abstract]
[Full Text]